UniProt ID | YBOX1_MOUSE | |
---|---|---|
UniProt AC | P62960 | |
Protein Name | Nuclease-sensitive element-binding protein 1 | |
Gene Name | Ybx1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 322 | |
Subcellular Localization | Cytoplasm. Nucleus. Cytoplasmic granule . Secreted. Shuttles between nucleus and cytoplasm. Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Shuttles between nucleus and cytoplasm. Predominantly cytoplasmic in proliferating cells | |
Protein Description | Mediates pre-mRNA alternative splicing regulation. Component of the CRD-mediated complex that promotes MYC mRNA stability. Binds to splice sites in pre-mRNA and regulates splice site selection. Binds and stabilizes cytoplasmic mRNA. Contributes to the regulation of translation by modulating the interaction between the mRNA and eukaryotic initiation factors. Binds to promoters that contain a Y-box (5'-CTGATTGGCCAA-3'), such as HLA class II genes. Regulates the transcription of numerous genes. Promotes separation of DNA strands that contain mismatches or are modified by cisplatin. Has endonucleolytic activity and can introduce nicks or breaks into double-stranded DNA (in vitro). May play a role in DNA repair. Its transcriptional activity on the multidrug resistance gene MDR1 is enhanced in presence of the APEX1 acetylated form at 'Lys-6' and 'Lys-7'. Binds preferentially to 5'-[CU]CUGCG-3' motif in vitro (By similarity).; The secreted form acts as an extracellular mitogen and stimulates cell migration and proliferation.. | |
Protein Sequence | MSSEAETQQPPAAPAAALSAADTKPGSTGSGAGSGGPGGLTSAAPAGGDKKVIATKVLGTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSKYAADRNHYRRYPRRRGPPRNYQQNYQNSESGEKNEGSESAPEGQAQQRRPYRRRRFPPYYMRRPYARRPQYSNPPVQGEVMEGADNQGAGEQGRPVRQNMYRGYRPRFRRGPPRQRQPREDGNEEDKENQGDETQGQQPPQRRYRRNFNYRRRRPENPKPQDGKETKAADPPAENSSAPEAEQGGAE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSSEAETQQ ------CCCHHHHCC | 36.56 | - | |
2 | Phosphorylation | ------MSSEAETQQ ------CCCHHHHCC | 36.56 | 26824392 | |
3 | Phosphorylation | -----MSSEAETQQP -----CCCHHHHCCC | 39.26 | 25619855 | |
7 | Phosphorylation | -MSSEAETQQPPAAP -CCCHHHHCCCCCHH | 39.28 | 25619855 | |
19 | Phosphorylation | AAPAAALSAADTKPG CHHHHHHHHHHCCCC | 19.38 | 25619855 | |
23 | Phosphorylation | AALSAADTKPGSTGS HHHHHHHCCCCCCCC | 34.12 | 25619855 | |
24 | Ubiquitination | ALSAADTKPGSTGSG HHHHHHCCCCCCCCC | 48.18 | - | |
27 | Phosphorylation | AADTKPGSTGSGAGS HHHCCCCCCCCCCCC | 37.82 | 25619855 | |
28 | Phosphorylation | ADTKPGSTGSGAGSG HHCCCCCCCCCCCCC | 41.08 | 25619855 | |
30 | Phosphorylation | TKPGSTGSGAGSGGP CCCCCCCCCCCCCCC | 26.09 | 20469934 | |
34 | Phosphorylation | STGSGAGSGGPGGLT CCCCCCCCCCCCCCC | 39.79 | 25619855 | |
41 | Phosphorylation | SGGPGGLTSAAPAGG CCCCCCCCCCCCCCC | 21.42 | 25619855 | |
42 | Phosphorylation | GGPGGLTSAAPAGGD CCCCCCCCCCCCCCC | 27.72 | 25619855 | |
56 | Ubiquitination | DKKVIATKVLGTVKW CCCEEEEEECEEEEE | 26.83 | - | |
56 | Acetylation | DKKVIATKVLGTVKW CCCEEEEEECEEEEE | 26.83 | 22826441 | |
62 | Ubiquitination | TKVLGTVKWFNVRNG EEECEEEEEEECCCC | 46.00 | 22790023 | |
70 | Phosphorylation | WFNVRNGYGFINRND EEECCCCEEEECCCC | 16.65 | 29514104 | |
78 | Phosphorylation | GFINRNDTKEDVFVH EEECCCCCCCCEEEE | 39.62 | 26370283 | |
79 | Ubiquitination | FINRNDTKEDVFVHQ EECCCCCCCCEEEEH | 55.57 | - | |
90 | Ubiquitination | FVHQTAIKKNNPRKY EEEHHHHHCCCHHHH | 47.16 | 22790023 | |
91 | Ubiquitination | VHQTAIKKNNPRKYL EEHHHHHCCCHHHHH | 56.71 | 22790023 | |
97 | Phosphorylation | KKNNPRKYLRSVGDG HCCCHHHHHEECCCC | 14.50 | 23984901 | |
100 | Phosphorylation | NPRKYLRSVGDGETV CHHHHHEECCCCCEE | 28.05 | 26824392 | |
106 | Phosphorylation | RSVGDGETVEFDVVE EECCCCCEEEEEEEE | 30.75 | 28833060 | |
134 | Phosphorylation | GGVPVQGSKYAADRN CCCCCCCCCCCCCCC | 12.85 | 29176673 | |
135 | Ubiquitination | GVPVQGSKYAADRNH CCCCCCCCCCCCCCC | 45.81 | 22790023 | |
135 | Acetylation | GVPVQGSKYAADRNH CCCCCCCCCCCCCCC | 45.81 | 23806337 | |
143 | Phosphorylation | YAADRNHYRRYPRRR CCCCCCCHHCCCHHH | 10.59 | 25367039 | |
156 | Phosphorylation | RRGPPRNYQQNYQNS HHCCCCCHHHHHCCC | 16.86 | 27149854 | |
160 | Phosphorylation | PRNYQQNYQNSESGE CCCHHHHHCCCCCCC | 12.53 | 25521595 | |
163 | Phosphorylation | YQQNYQNSESGEKNE HHHHHCCCCCCCCCC | 20.02 | 27087446 | |
165 | Phosphorylation | QNYQNSESGEKNEGS HHHCCCCCCCCCCCC | 52.66 | 27087446 | |
168 | Ubiquitination | QNSESGEKNEGSESA CCCCCCCCCCCCCCC | 64.92 | 22790023 | |
172 | Phosphorylation | SGEKNEGSESAPEGQ CCCCCCCCCCCCCCH | 23.38 | 27087446 | |
174 | Phosphorylation | EKNEGSESAPEGQAQ CCCCCCCCCCCCHHH | 51.31 | 27087446 | |
186 | Phosphorylation | QAQQRRPYRRRRFPP HHHHCCCCHHHCCCC | 18.23 | 29514104 | |
187 | Methylation | AQQRRPYRRRRFPPY HHHCCCCHHHCCCCH | 28.45 | 18966577 | |
194 | Phosphorylation | RRRRFPPYYMRRPYA HHHCCCCHHHCCCCC | 15.33 | 29514104 | |
195 | Phosphorylation | RRRFPPYYMRRPYAR HHCCCCHHHCCCCCC | 7.01 | 29514104 | |
197 | Methylation | RFPPYYMRRPYARRP CCCCHHHCCCCCCCC | 21.94 | 18601005 | |
206 | Phosphorylation | PYARRPQYSNPPVQG CCCCCCCCCCCCCCC | 17.07 | 25619855 | |
207 | Phosphorylation | YARRPQYSNPPVQGE CCCCCCCCCCCCCCC | 37.30 | 27087446 | |
237 | Methylation | PVRQNMYRGYRPRFR CCHHHHHCCCCCCCC | 25.54 | 54560689 | |
262 | Ubiquitination | EDGNEEDKENQGDET CCCCHHHHHCCCCCC | 62.94 | - | |
269 | Phosphorylation | KENQGDETQGQQPPQ HHCCCCCCCCCCCCC | 42.62 | 26525534 | |
285 | Phosphorylation | RYRRNFNYRRRRPEN HHHHHCCCCCCCCCC | 11.02 | 25367039 | |
294 | Ubiquitination | RRRPENPKPQDGKET CCCCCCCCCCCCCCC | 67.88 | - | |
299 | Ubiquitination | NPKPQDGKETKAADP CCCCCCCCCCCCCCC | 71.19 | - | |
299 | Acetylation | NPKPQDGKETKAADP CCCCCCCCCCCCCCC | 71.19 | - | |
302 | Acetylation | PQDGKETKAADPPAE CCCCCCCCCCCCCCC | 42.54 | - | |
302 | Ubiquitination | PQDGKETKAADPPAE CCCCCCCCCCCCCCC | 42.54 | - | |
311 | Phosphorylation | ADPPAENSSAPEAEQ CCCCCCCCCCCHHHH | 21.27 | 17203969 | |
312 | Phosphorylation | DPPAENSSAPEAEQG CCCCCCCCCCHHHHC | 60.47 | 27087446 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of YBOX1_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of YBOX1_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312, AND MASSSPECTROMETRY. | |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-172 AND SER-174, ANDMASS SPECTROMETRY. | |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-163 AND SER-172, ANDMASS SPECTROMETRY. | |
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-163 AND SER-312, ANDMASS SPECTROMETRY. |